Value Based Healthcare (VBHC) solutions to assess patient outcomes
WHO reports that almost 10% of global GDP is spent on healthcare. So how to measure efficiency of this expenditure? Value based healthcare concept that is centered at the patients’ outcomes is one of the probable answers. It is the wide spread of EMR and EHR systems and resulted accumulation of real world data that really brings VBHC to life and allows to provide in depth analysis of treatments value.
Regulatory decision-making support
Now regulators around the world start recognizing the potential and importance of this data for regulatory questions at hand. Growing reliability and relevance of RWD allows it to become a vital instrument in consideration for both pre- and post-market decisions.
Access to real world data can help understand current situation in specific geographies of interest regarding disease prevalence, treatment and prescription patterns. Traverse platform allows for regular updates with understanding campaign dynamics.
RWD can be used to identify genetic and molecular markers that predict response to drugs, which can be used to personalize treatment options.